Polymorphism of XRCC1 predicts overall survival of gastric cancer patients receiving oxaliplatin-based chemotherapy in Chinese population (Q80532477)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593927%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Polymorphism of XRCC1 predicts overall survival of gastric cancer patients receiving oxaliplatin-based chemotherapy in Chinese population (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593927%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

Baorui Liu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593927%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Jia Wei

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593927%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Zhengyun Zou

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593927%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Xiaoping Qian

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593927%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Takahiro Nakamura

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593927%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Wei Zhang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593927%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Yitao Ding

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593927%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Jifeng Feng

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593927%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Lixia Yu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593927%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

27 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593927%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Human Genetics

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593927%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593927%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

1049-1053

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593927%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593927%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.ejhg.5201884

1 January 2020

exact match

0 references

cites work

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201884

7 January 2021

Quality of life in patients with advanced gastric cancer: a randomized trial comparing docetaxel, cisplatin, 5-FU (TCF) with epirubicin, cisplatin, 5-FU (ECF)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201884

7 January 2021

Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201884

7 January 2021

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201884

7 January 2021

Predicting the outcome of chemotherapy for lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201884

7 January 2021

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201884

7 January 2021

Cancer pharmacogenetics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201884

7 January 2021

XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201884

7 January 2021

ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201884

7 January 2021

The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201884

7 January 2021

Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201884

7 January 2021

XRCC1 is required for DNA single-strand break repair in human cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201884

7 January 2021

XRCC1 interactions with base excision repair DNA intermediates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201884

7 January 2021

Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201884

7 January 2021

XRCC1, XRCC3, and XPD polymorphisms as modifiers of the effect of smoking and alcohol on colorectal adenoma risk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201884

7 January 2021

Selected DNA repair polymorphisms and gastric cancer in Poland

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201884

7 January 2021

Polymorphisms of DNA repair genes are risk factors for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201884

7 January 2021

Which gene is a dominant predictor of response during FOLFOX chemotherapy for the treatment of metastatic colorectal cancer, the MTHFR or XRCC1 gene?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201884

7 January 2021

Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201884

7 January 2021

Polymorphisms in XRCC1, XRCC3, and CCND1 and survival after treatment for metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201884

7 January 2021

Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201884

7 January 2021

Pharmacogenetic profiling and clinical outcome of patients with advanced gastric cancer treated with palliative chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201884

7 January 2021

Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201884

7 January 2021

Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201884

7 January 2021

A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201884

7 January 2021

Polymorphisms of the DNA repair gene XPD and risk of lung cancer in a Chinese population.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201884

7 January 2021

Genetic polymorphisms in glutathione-S-transferase genes (GSTM1, GSTT1, GSTP1) and survival after chemotherapy for invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201884

7 January 2021

Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS)--novel predictors for response and survival in gastric cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201884

7 January 2021

Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201884

7 January 2021

Cellular processing of platinum anticancer drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201884

7 January 2021

Identifiers

DOI

10.1038/SJ.EJHG.5201884

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17593927%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference